Since targeting MELK alone or with other treatment modalities has a possibility to overcome therapeutic resistance by suppressing CSCs as well as cancer proliferation, many efforts have been paid to develop a MELK kinase inhibitor(s) [14, 17]. The gene discussed is MELK; the disease is cancer.